Equities

Biotalys NV

Biotalys NV

Actions
  • Price (EUR)2.97
  • Today's Change-0.03 / -1.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 29 2024 10:55 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biotalys NV (formerly Agrosavfe NV) is a Belgium-based Food and Crop Protection company that provides agricultural solutions. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. It develops technology for sustainable crop protection. It offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. It also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR-20.51m
  • Incorporated2013
  • Employees77.00
  • Location
    Biotalys NVBuchtenstraat 11GENT 9051BelgiumBEL
  • Phone+32 92745400
  • Fax+32 92610699
  • Websitehttps://biotalys.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.